Professor Baker has written on theories of practice-based learning, critical
perspectives on legal writing and cross-cultural lawyering. He has taught and consulted
in South African law schools and law school clinics since 1997, particularly on issues of
legal skills, multiculturalism, human rights, and more recently HIV/AIDS and access to
medicines. Professor Baker co-teaches an intensive two-week IPR and access to medicines
course each July at the University of KwaZulu Natal where he is an honorary research

Professor Baker is a policy analyst for Health GAP (Global Access Project) and is
actively engaged in campaigns for universal access to treatment, prevention, and care for
people living with HIV/AIDS, especially expanded and improved medical treatment. He has
written and consulted extensively on intellectual property rights, trade, and access to
medicines, including with the African Union, ASEAN, Venezuela, CARICOM, Thailand, UK
DfID, the World Health Organization, the Millennium Development Goals Project, the Global
Fund to Fight AIDS, Tuberculosis and Malaria, Open Society Institute, UNDP, UNITAID, the
Medicines Patent Pool, the Global Commission on HIV and the Law, and others. He works on
policy issues concerning the Global Fund and the US PEPFAR Program, and how those
priority disease initiatives might contribute more broadly to improving health care
delivery in developing countries. Similarly, he works on issues involving human resources
for health and health system strengthening and is a member of the steering committee of
the Health Workforce Advocacy Initiative of the Global Health Workforce Alliance.
Finally, he analyzes resource needs for global health, innovative financing mechanisms,
and IMF macroeconomic policies that restrict increased government and donor spending on
health and education in developing countries. 



Governance and transparency at PEPFAR (with Matthew M. Kavanagh), Lancet Global Health (2014)

The US President's Emergency Plan for AIDS Relief (PEPFAR) has been one of the most...

Empowering patients and strengthening communities for real health workforce and funding targets, School of Law Faculty Publications (2013)

Setting ambitious targets for expanding the global health workforce and improving the quality, efficiency and...



Corporate Power Unbound: Investor-State Arbitration of IP Monopolies on Medicines – Eli Lilly and the TPP, PIJIP Research Paper Series (2013)

Free trade agreements (FTAs) and bilateral investment treaties (BITs) typically contain investment clauses designed to...



Leaked TPP investment chapter presents a grave threat to access to medicines, School of Law Faculty Publications (2012)

The leaked Trans-Pacific Partnership Investment Chapter has been analyzed extensively with respect to its dangerous...



Settlement of India/EU WTO dispute re seizures of in-transit medicines: why the proposed EU border regulation isn't good enough, School of Law Faculty Publications (2012)

European Customs officials have used fictive patent rights to justify the seizure of lawful generic...


Unpublished Papers


Corporate Power Unbound: Investor-State Arbitration of IP Monopolies on Medicines – Eli Lilly v. Canada and the Trans-Pacific Partnership Agreement (with Katrina Geddes), ExpressO (2015)

Despite the deep irony of free trade agreements being subverted to codify and extend anti-competitive...